KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Short term Debt (2017 - 2025)

Cardlytics (CDLX) has disclosed Short term Debt for 8 consecutive years, with $46.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Short term Debt rose 0.61% year-over-year to $46.1 million, compared with a TTM value of $46.1 million through Sep 2025, up 0.61%, and an annual FY2024 reading of $45.9 million, changed N/A over the prior year.
  • Short term Debt was $46.1 million for Q3 2025 at Cardlytics, roughly flat from $46.0 million in the prior quarter.
  • Across five years, Short term Debt topped out at $46.1 million in Q3 2025 and bottomed at $7000.0 in Q1 2021.
  • Average Short term Debt over 4 years is $29.0 million, with a median of $37.9 million recorded in 2023.
  • Peak annual rise in Short term Debt hit 84.21% in 2021, while the deepest fall reached 70.83% in 2021.
  • Year by year, Short term Debt stood at $35000.0 in 2021, then surged by 85614.29% to $30.0 million in 2023, then surged by 52.88% to $45.9 million in 2024, then increased by 0.45% to $46.1 million in 2025.
  • Business Quant data shows Short term Debt for CDLX at $46.1 million in Q3 2025, $46.0 million in Q2 2025, and $45.9 million in Q1 2025.